However, for TPα, as stated while its expression was more variable across the TMA, in those patient cases where its expression was actually increased in the tumour relative to the benign/BPH tissue there was a trend, albeit not significantly, toward a positive correlation between high TPα expression in tumour cores of patients that were BCR positive (P = 0.057; Table 2B). The gene discussed is BCR; the disease is benign prostatic hyperplasia.